Two decades of experience with ductal carcinoma in situ of the breast in the cancer institute of Tehran, Iran

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2771-2776

  Omranipour, Ramesh ^a   Alipour, Sadaf ^a,b   Hadji, Maryam ^a   Bagheri, Khojasteh ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast carcinoma; Ductal carcinoma in situ; Epidemiology; Iran; Screening

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; TIME; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS; YOUNG ADULT;

EID: 84899814326     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2771     Document Type: Article

References (51)

1. Atoum MF, Hourani HM, Shoter A, Al-Raheem SN, Al Muhrib TK (2010). Tnm staging and classification (familial and nonfamilial) of breast cancer in jordanian females. Indian J Cancer, 47, 194-8.
2. Aytac B, Sahsine T, Erturk FY, Kahveci R, Gokgoz S (2013). Evaluation of incidence and histolopathological findings of breast lesions in reduction mammoplasty specimens: Uludag university experience. J Pak Med Assoc, 63, 878-81.
3. Badruddoja M (2012). Ductal carcinoma in situ of the breast: A surgical perspective. Int J Surg Oncol, 2012, 761364.
4. Bleyer A, Welch HG (2012). Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med, 367, 1998-2005.
5. Brennan ME, Turner RM, Ciatto S, et al (2011). Ductal carcinoma in situ at core-needle biopsy: Meta-analysis of underestimation and predictors of invasive breast cancer. Radiology, 260, 119-28.
6. Chan LK, Lam HS, Chan ES, et al (1998). Mammogram screening of chinese women in kwong wah hospital, hong kong. Australas Radiol, 42, 6-9.
7. Choi DX, Van Zee KJ (2012). Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast. Int J Surg Oncol, 2012, 723916.
8. Chua CL, Tan K, Chiang G, Soo KC, Low CH (1992). Breast carcinoma-in-situ: An emerging problem in singapore. Singapore Med J, 33, 383-5.
9. Chuwa EW, Tan VH, Tan H, et al (2008). Treatment for ductal carcinoma in situ in an asian population: Outcome and prognostic factors. ANZ J Surg, 78, 42-8.
10. Estevez LG, Alvarez I, Segui MA, et al (2010). Current perspectives of treatment of ductal carcinoma in situ. Cancer Treat Rev, 36, 507-17.
11. Fortunato L, Poccia I, De Paula U, Santini E (2012). Ductal carcinoma in situ: what can we learn from clinical trials? Int J Surg Oncol, 2012, 296829.
12. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7.
13. Hunt Kk NL, Copeland Iii Em, Bland Kl (2010). The breast, in: A. D. Brunicardi Fc, Billiar Tr, Dunn Dl, Hunter Jg, Matthews Jb, Pollock Re (Ed.) Schwartz's Principles of Surgery. 9th ed. (USA, McGraw-Hill), 424-6.
14. Ikeda T, Jinno H, Matsui A, et al (2002). Overview: current status of breast conserving therapy in japan. Biomed Pharmacother, 56, 182-6.
15. Izumori A, Takebe K, Sato A (2010). Ultrasound findings and histological features of ductal carcinoma in situ detected by ultrasound examination alone. Breast Cancer, 17, 136-41.
16. Jara-Lazaro AR, Thilagaratnam S, Tan H (2010). Breast cancer in singapore: Some perspectives. Breast Cancer, 17, 23-8.
17. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
18. Kayani N, Bhurgri Y (2005). Ductal carcinoma in situ (DCIS) in Karachi. J Pak Med Assoc, 55, 199-202.
19. Kokubo M, Mitsumori M, Kanehira K, et al (2001). Results of breast-conserving therapy for ductal carcinoma in situ: the Kyoto University experiences. Breast Cancer, 8, 153-7.
20. Lambert K, Patani N, Mokbel K (2012). Ductal carcinoma in situ: recent advances and future prospects. Int J Surg Oncol, 2012, 347385.
21. Lee RJ, Vallow LA, Mclaughlin SA, et al (2012). Ductal carcinoma in situ of the breast. Int J Surg Oncol, 2012, 123549.
22. Leeper AD, Dixon JM (2011). DCIS of the breast: Are we over-diagnosing it? Are we over-treating it? Maturitas, 68, 295-6.
23. Livaudais JC, Hwang ES, Karliner L, et al (2012). Adjuvant hormonal therapy use among women with ductal carcinoma in situ. J Womens Health, 21, 35-42.
24. Lui CY, Lam HS, Chan LK, et al (2007). Opportunistic breast cancer screening in hong kong; a revisit of the kwong wah hospital experience. Hong Kong Med J, 13, 106-13.
25. Macmahon B, Morrison AS, Ackerman LV, et al (1973). Histologic characteristics of breast cancer in boston and tokyo. Int J Cancer, 11, 338-44.
26. Mun HS, Shin HJ, Kim HH, Cha JH, Kim H (2013). Screening-detected calcified and non-calcified ductal carcinoma in situ: Differences in the imaging and histopathological features. Clin Radiol, 68, 27-35.
27. Parikh RR, Haffty BG, LanninD, Moran MS (2012.) Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Int J Radiat Oncol Biol Phys, 82, 7-13.
28. Park HS, Park S, Cho J, et al (2013). Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J Surg Oncol, 107, 388-92.
29. Parkin D M, Bray F, Ferlay J, Pisani (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
30. Patani N, Khaled Y, Al Reefy S, Mokbel K (2011). Ductal carcinoma in situ: An update for clinical practice. Surg Oncol, 20, 23-31.
31. Pimiento JM, Lee MC, Esposito NN, et al (2011). Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract, 7, 309-13.
32. Sacchini V, Fortunato L, Cody Iii HS, et al (2012). Breast ductal carcinoma in situ. Int J Surg Oncol, 2012, 753267.
33. Schmale I, Liu S, Rayhanabad J, Russell CA, Sener SF (2012). Ductal carcinoma in situ (DCIS) of the breast: perspectives on biology and controversies in current management. J Surg Oncol, 105, 212-20.
34. Schneider C, Trocha S, Mckinley B, et al (2010). The use of sentinel lymph node biopsy in ductal carcinoma in situ. Am Surg, 76, 943-6.
35. Scripcaru G, Zardawi IM (2012). Mammary ductal carcinoma in situ: a fresh look at architectural patterns. Int J Surg Oncol, 2012, 979521.
36. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ (2002). Global and regional estimates of cancer mortality and incidence by site: Ii. Results for the global burden of disease 2000. BMC Cancer, 2, 37.
37. Shulman LN, Willett W, Sievers A, Knaul FM (2010). Breast cancer in developing countries: O ortunities for improved survival. J Oncol, 2010, 595167.
38. Siziopikou KP (2013) Ductal carcinoma in situ of the breast: Current concepts and future directions. Arch Pathol Lab Med, 137, 462-6.
39. Sorum R, Hofvind S, Skaane, Haldorsen T (2010). Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast, 19, 499-505.
40. Tan KB, Lee HY, Putti TC (2002a). Ductal carcinoma in situ of the breast in singapore: recent trends and clinical implications. ANZ J Surg, 72, 793-7.
41. Tan H, Chuah KL, Chiang G, et al (2002b). Correlation of p53 and cerbb2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast. Oncol Rep, 9, 1081-6.
42. Tan H, Ho JT, Ng EH, et al (2000). Pathologic-radiologic correlations in screen-detected ductal carcinoma in situ of the breast: findings of the Singapore breast screening project. Int J Cancer, 90, 231-6.
43. Tfayli A, Temraz S, Abou Mrad R, Shamseddine A (2010). Breast cancer in low- and middle-income countries: an emerging and challenging epidemic. J Oncol, 2010, 490631.
44. Tuncbilek I, Ozdemir A, Gultekin S, et al (2007). Clinical outcome assessment in mammography: an audit of 7,506 screening and diagnostic mammography examinations. Diagn Interv Radiol, 13, 183-7.
45. Usmani S, Khan HA, Al Saleh N, et al (2011). Selective a roach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast. Nucl Med Commun, 32, 1084-7.
46. Wang LC, Sullivan M, Du H, Feldman MI, Mendelson EB (2013). Us a earance of ductal carcinoma in situ. Radiographics, 33, 213-28.
47. Wang SC (2003). The singapore national breast screening programme: principles and implementation. Ann Acad Med Singapore, 32, 466-76.
48. Wu GH, Chen LS, Chang KJ, et al (2006) Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer. J Med Screen, 13, 23-7.
49. Yau TK, Chan K, Chant M, et al (2006). Wide local excision and radiotherapy for the treatment of ductal carcinoma in situ of the breast: The hong kong experience. Clin Oncol, 18, 447-52.
50. Yeoh KG, Chew L, Wang SC (2006). Cancer screening in singapore, with particular reference to breast, cervical and colorectal cancer screening. J Med Screen, 13, 14-9.
51. Zhang W, Gao EL, Zhou YL, et al (2012). Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer. World J Surg Oncol, 10, 262.